Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States

BMC Public Health

Table 2 Epidemiology of invasive pneumococcal disease (IPD) in the U.S. elderly population, 2007-2008

	Age cohorts
	65-69	70-79	≥80	Source
IPD cases per 100,000 per year in the general population (all races)	25.9	33.9	60.1	[ABCs^a]
African-American population	41.6	54.5	96.4	[Estimate^bc]
Hispanic population	34.0	44.6	78.9	[Estimate^bd]
African-American, Hispanic weighted average	38.2	50.0	88.6	[Estimate^be]
IPD outcomes per 100,000 per year in the general population (all races)
IPD meningitis	1.6	1.3	1.3	[ABCs]
IPD death	2.9	3.9	11.9	[ABCs]
Pneumococcal polysaccharide vaccine serotype coverage (all races)	74.1%	65.8%	62.9%	[ABCs]
Population immunocompromised (all races)	13.1%	20.2%	23.8%	[ABCs]

^aABCs: Active Bacterial Core Surveillance (ABCs) network, 2007–2008.
^bEstimates of race-level IPD incidence do not include corrections for prior vaccination status explained in the text.
^cBased on ABCs population level data on incidence of IPD in the African-American population.
^dBased on relative incidence of IPD in African-American and Hispanic pediatric populations [37].
^eBased on incidence of IPD in African-American and Hispanic elderly populations and relative population sizes [18].

ISSN: 1471-2458